Metagenomic Profiling of Ocular Surface Microbiome Changes in Meibomian Gland Dysfunction/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Svetlana up on 2025-1-21

Curated date: 2024/11/04

Curator: Rahila

Revision editor(s): Rahila, Aleru Divine

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Meibum Tarsal gland secretion,Meibum,meibum
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Meibomian cyst chalazia,Chalazion,chalazion,cyst, Meibomian,Meibomian cyst,meibomian gland lipogranuloma,meibomian cyst
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy Control (HCs)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Meibomian gland dysfunction (MGD)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients diagnosed with Meibomian gland dysfunction (MGD)
Group 0 sample size Number of subjects in the control (unexposed) group
15
Group 1 sample size Number of subjects in the case (exposed) group
61
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
6 months.

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Welch's T-Test
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
decreased
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-1-21

Curated date: 2024/11/05

Curator: Rahila

Revision editor(s): Rahila, Aleru Divine

Source: Table 1 and Supplementary Figure S2D

Description: Pathogens with differential incidences in meibum between MGD patients and healthy controls (p<0.05)

Abundance in Group 1: increased abundance in Meibomian gland dysfunction (MGD)

NCBI Quality ControlLinks
Bacillus licheniformis
Campylobacter coli
Campylobacter jejuni
Enterococcus faecium
Escherichia coli
Malassezia globosa
Pseudomonas aeruginosa
Pseudomonas fluorescens
Pseudomonas protegens
Ralstonia pickettii
Yarrowia lipolytica

Revision editor(s): Rahila, Aleru Divine

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2025-1-21

Curated date: 2025/01/21

Curator: Aleru Divine

Revision editor(s): Aleru Divine

Source: Table 1 and Supplementary Figure S2D

Description: Pathogens with differential incidences in meibum between MGD patients and healthy controls (p<0.05)

Abundance in Group 1: decreased abundance in Meibomian gland dysfunction (MGD)

NCBI Quality ControlLinks
Pseudomonas mosselii
Enterobacter cloacae complex
Comamonas testosteroni
Serratia marcescens
Stenotrophomonas maltophilia
Neisseria sicca
Neisseria meningitidis
Roseomonas gilardii
Staphylococcus capitis

Revision editor(s): Aleru Divine